Reston Patients: Our elevators currently are out of service. We apologize for any inconvenience. Please call 571.350.8400 if you need to reschedule today’s appointment.

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C - Co-Author Alexandar Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

January 09, 2023

Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira » Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C – Co-Author Alexandar Spira, MD, PhD, FACP

Adagrasib With or Without Cetuximab Produces Encouraging Clinical Activity in KRAS G12C–Mutant CRC – Co-Author Alexander I. Spira, MD, PhD, FACP

https://www.nejm.org/doi/full/10.1056/NEJMoa2212419

Alexander I Spira MD, PhD, FACP, FASCO

Medical Oncologist

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More

Return to Top

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C - Co-Author Alexandar Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

January 09, 2023

Adagrasib With or Without Cetuximab Produces Encouraging Clinical Activity in KRAS G12C–Mutant CRC – Co-Author Alexander I. Spira, MD, PhD, FACP

Recent Posts

Temporary Elevator Service Disruption at Reston Location - May 12th

May 12, 2026

Breakthrough Targeted Therapy Shows Promise for KRAS‑Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role

May 12, 2026

Myeloma Matters: A Mid-day Talk with a Doc, Thursday, April 16 12:30-1:30pm Dipti Patel Donnelly, MD

April 2, 2026

Weather Advisory: Monday, March 16, 2026

March 16, 2026

New OncoTalks Episode: Advancing Biomarker Testing in NSCLC - Dr. Alexander I. Spira, MD, PhD, FACP, FASCO

February 9, 2026

Award Winning Physicians